Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs

This publication has 12 references indexed in Scilit:

• Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
  Circulation, 1989
• Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation
  The American Journal of Cardiology, 1987
• Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias
  JACC, 1986
• Electrophysiologic properties of flecainide acetate
  The American Journal of Cardiology, 1984
• Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate
  American Heart Journal, 1984
• Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
  Circulation, 1983
• Electrophysiology of oral encainide
  The American Journal of Cardiology, 1982
• Malignant ventricular tachyarrhythmias associated with the use of encainide
  American Heart Journal, 1981
• Studies of Atrial Flutter Following Open Heart Surgery
  Annual Review of Medicine, 1979
• Recurrent sustained ventricular tachycardia. 1. Mechanisms.
  Circulation, 1978